[ad_1]
Copy link
The British Medicines and Health Regulatory Agency (MHRA) has warned thousands of heart patients and urged them to check their drugs, fearing that they contain carcinogenic chemicals.
The agency stressed the fear of a drug that may contain carcinogens and called on the country's pharmacies to recover all the drugs "irbesartan", the third such request since the beginning of the year, the British newspaper "The Sun".
The agency pointed out that there is no evidence to date that the drug causes any harmful effects to patients, which means that you should not stop taking these drugs without consulting the doctor, as this may lead to life in danger.
"Patient safety is our top priority, and we will take all necessary steps to protect public health," said Dr. Sam Atkinson, Director of the Ministry's Department of Investigation, Standards and Standards. Human Rights.
These warnings follow earlier reports, which led to the recall of heart medications such as Dexcel, Actavis in July, Mylan and Teva in November, containing the same chemical.
Experts are concerned that the so-called medicines contain "N-nitrosodimethylamine" and "N-nitrosodiethylamine", which may be carcinogenic and present in drugs as a result of changes in manufacturing processes.
The European Medicines Agency and other organizations of the EU are working together to study the extent of this problem and its potential impact on patients.
[ad_2]
Source link
